MaRS Innovation Staff Member Jackie Terry on Her Olympic Legacy
Olympians from all over the world are gathering today in London, England for the Opening Ceremony of the Games of the XXX Olympiad. For the thousands of athletes set to…
BioCentury Features Xagenic’s PCR-Based Infection-Diagnosis Technology
Xagenic, a MaRS Innovation spin-off company, was featured in the most recent issue of BioCentury. Here's an excerpt (the article only available to BioCentury subscribers): PCR-based diagnosis of infections can…
Los Angeles Times covers Dr. Gregory Czarnota’s cancer therapy technology
The Los Angeles Times featured Dr. Gregory Czarnota’s research in their Science Now section on July 10, 2012, which reports on discoveries from the world of science and medicine (update: the article is no longer available online).
Czarnota, a researcher at the Sunnybrook Health Sciences Centre, is working with MaRS Innovation to license his patented technology: radiosensitization of tumour cells using a combination of microbubbles and targeted, high-intensity, focused ultrasound.
MaRS Innovation’s Lead Start-Up Completes $20 Million Series B
Xagenic’s financing round to test platform and first diagnostic assay, continue product development and begin FDA submission Toronto, ON (December 2, 2013) — MaRS Innovation’s first start-up company, Xagenic Inc.,…
Business Without Borders features Encycle Therapeutics, Raphael Hofstein
Encycle Therapeutics, a MaRS Innovation spin-off company, was featured by Business Without Borders' High Tech section in a Q&A profile with MI's President and CEO, Raphael Hofstein. Here's an excerpt:…